199 related articles for article (PubMed ID: 4896110)
21. Epidermal cytoplasmic antibodies. (Incidence and clinical significance).
Betterle C; Peserico A; Bersani G; Rigon F; Del Prete G
Ric Clin Lab; 1977; 7(3):242-51. PubMed ID: 343221
[TBL] [Abstract][Full Text] [Related]
22. Humoral response of melanoma patients to two different tumor-associated antigens.
Chee DO; Gupta RK; Morton DL
J Surg Oncol; 1983 Aug; 23(4):228-35. PubMed ID: 6876798
[TBL] [Abstract][Full Text] [Related]
23. [Immunology of malignant melanoma].
Bourgoin JJ
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):789-807. PubMed ID: 4559237
[No Abstract] [Full Text] [Related]
24. Epidermal cytoplasmic antibodies: incidence and type in normal persons and patients with melanoma.
Abel EA; Bystryn JC
J Invest Dermatol; 1976 Jan; 66(1):44-8. PubMed ID: 1107434
[TBL] [Abstract][Full Text] [Related]
25. Immunity to melanoma associated antigens detected by both leukocyte adherence inhibition and antibody dependent cellular cytotoxicity assays.
Plain MJ; Whitehead RH; Jose DG
Pathology; 1983 Apr; 15(2):177-82. PubMed ID: 6888965
[TBL] [Abstract][Full Text] [Related]
26. Clinical and immunological significance of human melanoma cytotoxic antibody.
Bodurtha AJ; Chee DO; Laucius JF; Mastrangelo MJ; Prehn RT
Cancer Res; 1975 Jan; 35(1):189-93. PubMed ID: 1109788
[TBL] [Abstract][Full Text] [Related]
27. Immunofluorescent studies of the serologic reactivity of patients with malignant melanoma against tumor-associated cytoplasmic antigens.
Wood GW; Barth RF
J Natl Cancer Inst; 1974 Aug; 53(2):309-16. PubMed ID: 4602060
[No Abstract] [Full Text] [Related]
28. Immunofluorescent studies on chimpanzee humoral responses to human melanoma cells.
Leong SP; Hornung MO; Krementz ET
Oncology; 1976; 33(5-6):246-9. PubMed ID: 800239
[TBL] [Abstract][Full Text] [Related]
29. Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo.
Yu HS; Kao CH; Yu CL
J Invest Dermatol; 1993 Jun; 100(6):823-8. PubMed ID: 8496622
[TBL] [Abstract][Full Text] [Related]
30. Demonstration of specific serologic reactivity in human osteosarcoma.
Sindelar WF
Cancer; 1983 Feb; 51(3):444-51. PubMed ID: 6185204
[TBL] [Abstract][Full Text] [Related]
31. Augmentation of autologous antibody to human melanoma following acid dissociation and ultrafiltration of serum.
Kirkwood JM; Vlock DR
Cancer Res; 1984 Sep; 44(9):4177-82. PubMed ID: 6744327
[TBL] [Abstract][Full Text] [Related]
32. Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody.
Real FX; Mattes MJ; Houghton AN; Oettgen HF; Lloyd KO; Old LJ
J Exp Med; 1984 Oct; 160(4):1219-33. PubMed ID: 6237165
[TBL] [Abstract][Full Text] [Related]
33. Anti-tumour auto-antibody in human malignant melanoma.
Mansell PW; Verrier-Jones J
J Pathol; 1971 Feb; 103(2):Pxv. PubMed ID: 4936065
[No Abstract] [Full Text] [Related]
34. Anticarbohydrate autoantibodies to sialidase-treated erythrocytes and thymocytes in serum from patients with pulmonary sarcoidosis.
Pilatte Y; Tisserand EM; Greffard A; Bignon J; Lambré CR
Am J Med; 1990 May; 88(5):486-92. PubMed ID: 2186624
[TBL] [Abstract][Full Text] [Related]
35. Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen.
Currie GA; Basham C
Br J Cancer; 1972 Dec; 26(6):427-38. PubMed ID: 4119105
[TBL] [Abstract][Full Text] [Related]
36. [Characterization of antigens reacting with vitiligo and cytoplasmic melanoma antibodies].
Presser HJ; Morenz J; Höfs T; Zugehör M; Kühne KH; Brödemann M
Dermatol Monatsschr; 1987; 173(8):441-5. PubMed ID: 3311840
[No Abstract] [Full Text] [Related]
37. Production of antisera with specificity for malignant melanoma and human fetal skin.
Fritze D; Kern DH; Drogemuller CR; Pilch YH
Cancer Res; 1976 Feb; 36(2 Pt 1):458-66. PubMed ID: 56991
[TBL] [Abstract][Full Text] [Related]
38. Circulating anti-tumor and autoantibodies in breast carcinoma: relationship to stage and prognosis.
Lee YT; Sheikh KM; Quismorio FP; Friou GJ
Breast Cancer Res Treat; 1985; 6(1):57-65. PubMed ID: 3902126
[TBL] [Abstract][Full Text] [Related]
39. Fluorescent antibody studies in malignant melanoma.
Whitehead RH
Br J Cancer; 1973 Dec; 28(6):525-9. PubMed ID: 4205845
[TBL] [Abstract][Full Text] [Related]
40. Immunologic changes in regional lymph nodes of melanoma patients.
Hammer C; Lewis MG; Rowden G; Phillips T
Chir Forum Exp Klin Forsch; 1978; (1978):235-8. PubMed ID: 313322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
